Get the Stockscreener App
20.39
6.03%
1.16
After Hours:
20.00
-0.39
-1.91%
Instil Bio Inc stock is traded at $20.39, with a volume of 159.90K.
It is up +6.03% in the last 24 hours and down -15.39% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$19.23
Open:
$19.77
24h Volume:
159.90K
Relative Volume:
1.00
Market Cap:
$137.65M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-1.7902
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
+10.63%
1M Performance:
-15.39%
6M Performance:
+35.66%
1Y Performance:
-51.53%
1-Day Range:
$19.77
$21.80
1-Week Range:
$17.67
$21.98
52-Week Range:
$10.80
$45.07
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
20.39 | 129.82M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
Can Instil Bio Inc. hit a new high this monthGDP Growth & Pattern Based Trade Signal System - newser.com
Why Instil Bio Inc. stock could benefit from AI revolutionEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
Why Instil Bio Inc. stock remains on buy listsStock Surge & Stock Portfolio Risk Control - newser.com
Backtesting results for Instil Bio Inc. trading strategiesEarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
What’s next for Instil Bio Inc. stock price2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Relative strength of Instil Bio Inc. in sector analysisJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Technical signs of recovery in Instil Bio Inc.Market Sentiment Review & Safe Capital Growth Stock Tips - newser.com
What Analyst Ratings Reveal About Garnet International Limiteds Future ValueTechnical Analysis Insights & Breakthrough Investment Results - earlytimes.in
Instil Bio Inc. stock daily chart insightsTrade Risk Report & Community Verified Swing Trade Signals - newser.com
Quantitative breakdown of Instil Bio Inc. recent moveInflation Watch & Reliable Intraday Trade Plans - newser.com
Combining price and volume data for Instil Bio Inc.Market Movement Recap & AI Driven Stock Price Forecasts - newser.com
What drives Instil Bio Inc stock priceInsider Selling Patterns & Free Unlock Portfolio Growth - earlytimes.in
What technical models suggest about Instil Bio Inc.’s comebackEarnings Growth Summary & Expert Curated Trade Setup Alerts - newser.com
Institutional scanner results for Instil Bio Inc.Portfolio Gains Report & Consistent Income Trade Ideas - newser.com
How to read the order book for Instil Bio Inc.Fed Meeting & Daily Market Momentum Tracking - newser.com
What analysts say about Instil Bio Inc stockTrendline Breakouts & Turn Market Volatility into Wealth - earlytimes.in
Volume Sustainability Need for continued volume supportBreakout Stock Watch & Free Tremendous Return On Equity - earlytimes.in
What the charts say about Instil Bio Inc. todayBull Run & Weekly High Potential Stock Alerts - newser.com
Day 8 of Loss Streak for Instil Bio Stock with -35% Return (vs. -13% YTD) [9/25/2025] - Trefis
How Instil Bio Inc. stock reacts to Fed rate cuts2025 Market Trends & Daily Volume Surge Signals - The British Mountaineering Council
Instil Bio Inc. stock chart pattern explained2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com
Citizens JMP Maintains Instil Bio(TIL.US) With Hold Rating - 富途牛牛
Will Instil Bio Inc. see short term momentumFed Meeting & Weekly High Potential Stock Alerts - newser.com
Leading vs lagging indicators on Instil Bio Inc. performanceInflation Watch & Verified Stock Trade Ideas - newser.com
Volume spikes in Instil Bio Inc. stock – what they meanJuly 2025 Outlook & Long-Term Safe Investment Ideas - newser.com
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Instil Bio Inc Stock (TIL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO |
Sep 10 '25 |
Sale |
23.39 |
30,000 |
701,667 |
0 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):